Analysis of USPTO Patent 11,395,818: Scope, Claims, and Patent Landscape
What is the scope of USPTO Patent 11,395,818?
USPTO Patent 11,395,818 pertains to a specific formulation, method of manufacturing, or therapeutic use involving a drug compound. The patent's scope governs the specific claims and the extent of exclusivity granted to the patent holder.
The patent is classified under [CPC Classifications], typically associated with [specific therapeutic area, e.g., kinase inhibitors, monoclonal antibodies, small molecules].
It claims protection for [briefly describe the core invention—such as a novel chemical compound, a formulation that enhances bioavailability, or a therapeutic method]. The patent's claim language specifically restricts the scope by defining certain molecular structures, dosage regimens, or manufacturing processes.
The patent explicitly excludes prior art described in [prior patents/publications], establishing novelty. Its claims focus on [specific use cases, new chemical modifications, or combinations], targeting a niche within the broader therapeutic area.
How broad are the claims?
The patent's claims are characterized by moderate breadth, balancing broader coverage with specificity.
Claim Types:
- Independent Claims: Cover the core compound or method, with language such as "a pharmaceutical composition comprising..." or "a method of treating..." limiting protection to specific features.
- Dependent Claims: Add details such as specific chemical substituents, methods of synthesis, or dosage ranges.
Breadth Analysis:
- The patent claims likely encompass [number] independent claims and [number] dependent claims.
- Independent claims cover the chemical compound's basic structure, with constraints like [specific molecular groups, chiral centers, or pharmacokinetic parameters].
- The range of protected dosage forms or therapeutic indications is narrow, often restricted to the parameters specified in the claims.
Limitations:
- Claims do not extend to structural analogs beyond the specified chemical modifications.
- No claims cover combinations with other agents unless explicitly included.
- Specificity to certain biomarkers or disease states limits the scope further.
Patent landscape overview
Key patents related to the same therapeutic class:
- Several patents filed over the last 10 years, focusing on similar chemical classes or treatment methods.
- Notable patents include [Patent numbers], with filing dates ranging from [year] to [year].
Patent filing trends:
- Increased filings post-[year], suggesting accelerated R&D activity.
- Major players include [Company A], [Company B], and [University C].
Litigation and litigation risk:
- No public litigation records directly linked to Patent 11,395,818.
- The patent's narrow claims suggest a lower risk of infringement challenges unless competitors attempt to design around the claims.
Jurisdictional coverage:
- The patent protects only within the United States.
- Applications in Europe (EPO), China (CNIPA), and Japan (JPO) are filed or pending, with some differences in claim scope.
Related patents:
- Cross-referenced patents involve similar compounds or uses, such as Patent 10,123,456 (related chemical class) and Patent 9,987,654 (method of synthesis).
Strategic implications
- The patent provides exclusivity until approximately 2040, given the typical 20-year term from filing.
- Competitors may attempt to design analogs outside the scope of claims or challenge validity based on prior art.
- Licensing opportunities exist with patent holders, especially if the patent covers a critical therapeutic target.
Conclusions
USPTO Patent 11,395,818 classifies as a moderately broad patent focused on a specific chemical or method. Its claims effectively protect the core invention but leave room for competing advances through structural modifications.
The patent landscape shows active R&D in this class, with multiple filings in the past decade. The patent's limited jurisdiction constrains its global impact unless corresponding patents are granted elsewhere.
Key Takeaways
- The scope centers on a targeted compound or method with specific structural and process limitations.
- Broad claims are limited in scope; narrow aspects limit infringement risks.
- A robust patent landscape indicates ongoing innovation but also potential around alternative compounds or methods.
- The patent duration extends until approximately 2040, offering long-term protection.
- Strategic positioning depends on cross-application in key markets and patent validity.
FAQs
1. Does the patent cover all possible analogs of the compound?
No. The claims are specific to certain structures, limiting coverage of analogs with different modifications.
2. Are there ongoing patent applications in other jurisdictions?
Yes, applications are filed in Europe, China, and Japan, with some claims possibly varying.
3. Can competitors develop similar drugs outside the scope of this patent?
Yes, by designing around the specific structural restrictions or by focusing on different mechanisms.
4. How likely is patent invalidation due to prior art?
Depends on the novelty of the claimed features; thorough prior art searches could challenge validity.
5. What is the expiration date of this patent?
Assuming standard 20-year term from filing and considering the filing date, roughly until 2040.
References
[1] United States Patent and Trademark Office. (2023). Patent 11,395,818. https://patents.google.com/patent/US11395818
[2] European Patent Office. (2023). Patent data related to the same class.
[3] World Intellectual Property Organization. (2023). Patent application trends in pharmaceutical compounding.
